Prof. Kenneth Kaitin, Professor of Public Health and Medicine at Tufts School of Medicine

Om avsnittet

Pharmaceutical R&D trends and costs, Value chain paradigms, Basic v/s translational research, Investment needs, and COVID 19

Prof. Kenneth Kaitin is a professor of Public Health and Medicine at Tufts School of Medicine and the Director of the Tufts Center for the Study of Drug Development. He is also an Advisory Professor at Shanghai Medical College at Fudan University in Shanghai, and a consultant to the U.S. Department of Defense on bioterror countermeasures. Ken’s research focuses on the economic, scientific, regulatory, and political factors that affect pharmaceutical development.

Om avsnittet

Fler avsnitt

Prof. Alex Chan of Harvard on Explainable AI, Medical liability of AI, and the collapse of WWW.

Prof. Zaldy Tan of UCLA on What to Remember When You Are Forgetting

Prof. Mark Mattson of Johns Hopkins on metabolic switching and intermittent fasting

Prof. Rachael Brown of the University of Chicago on Christians and Christianity

Prof. Trevor Robbins of Univ. of Cambridge on the neural basis of compulsive disorders

Prof. Eric Betzig of Univ. of California, Berkely on high resolution imaging of biological systems

Prof. Emil Martinec of the University of Chicago on String theory & black holes information paradox

Prof. Jonathan Silvertown of the Univ. of Edinburgh on how leaves conjure up the world

Prof. Stephanie Schmitt-Grohe of Columbia University on the Neo-Fisher Effect in Monetary Policy

Prof. Mariassunta Giannetti on supply chains, market power, inflation and liquidity reallocation